Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Tenon Medical (TNON) Asset Writedowns and Impairment (2024)

Tenon Medical has reported Asset Writedowns and Impairment over the past 1 years, most recently at -$5000.0 for Q4 2024.

For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$5000.0; the TTM value through Dec 2024 reached $41000.0, changed N/A, while the annual FY2025 figure was $16000.0, 60.98% down from the prior year.
Asset Writedowns and Impairment for Q4 2024 was -$5000.0 at Tenon Medical, down from $36000.0 in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $36000.0 in Q2 2024 and troughed at -$5000.0 in Q4 2024.